Harnessing the Titans of Vascular Dementia: Hypertension, Diabetes, and Obesity

Vascular and neurodegenerative causes of cognitive impairment and dementia have long been thought of as separate entities with no linkage by way of mechanisms of causation. More recently, however, cardiovascular risks have been linked to neurodegenerative disease such as Alzheimer’s dementia (AD) and other neurodegenerative disorders. These new associations provide a potential treatment and prevention pathway for not only vascular disease and vascular forms of cognitive impairment, but also for AD. In this course we will explore:

  • How the paradigm shift occurred to include cardiovascular risks as possible risks for both vascular dementia, and AD and other neurodegenerative forms of dementia;
  • Mechanisms underlying the role of hypertension, diabetes and obesity in the causation of cognitive impairment and dementia; and
  • Results of clinical trials designed to treat hypertension, diabetes and obesity to protect the brain and as forerunners to what the provider in practice may do at the individual patient level to prevent cognitive impairment and dementia in later life.

Learning Objectives

  • Discuss why the paradigm shifted and cardiovascular risks became associated with both neurodegenerative and vascular forms of cognitive impairment and dementia
  • Discuss mechanisms underlying hypertension in the causation of cognitive impairment and dementia
  • Discuss mechanisms underlying diabetes mellitus in the causation of cognitive impairment and dementia
  • Discuss mechanisms underlying obesity in the causation of cognitive impairment and dementia
  • Review lessons learned from clinical trials and studies regarding treatment of cardiovascular risk in patients

Additional Information

AttachmentSize
PDF icon Slides and Disclosures7.7 MB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/25/2021
Course expires: 
06/24/2022
Rating: 
0

Philip Gorelick, MD, MPH

Professor of Translational Neuroscience
Michigan State University College of Human Medicine

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.